Trending Articles

article thumbnail

Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma

MedCity News

Bain Capitals buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and metabolic disease. This business is the pharmaceuticals division of Japanese conglomerate Mitsubishi Chemical Group. The post Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma appeared first on MedCity News.

Pharma 103
article thumbnail

Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn

Pharmaceutical Technology

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the strong growth potential of Japans healthcare industry.

Pharma 104
article thumbnail

The Future of Training: How Virtual Reality Can Protect Clinicians from Healthcare-associated Infections

MedCity News

VR allows learners to actually see the virtual germs responsible for causing infections and spreading disease, which could otherwise only be seen under a microscope. The technology also heightens users’ senses, drawing their attention to things they would be unable to see in traditional learning environments. The post The Future of Training: How Virtual Reality Can Protect Clinicians from Healthcare-associated Infections appeared first on MedCity News.

Training 120
article thumbnail

FDA clears new antibiotic for superbug infections

pharmaphorum

AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.

FDA 96
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

MHRA approves SARCLISA for newly diagnosed multiple myeloma

European Pharmaceutical Review

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for SARCLISA (isatuximab), making it the first and only anti-CD38 quadruplet therapy available for patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant (ASCT). This decision provides a new first-line treatment option for thousands of patients in the UK facing this blood cancer.

article thumbnail

Capgemini unveils AI breakthrough to boost bioeconomy

PharmaTimes

New methodology may boost innovation in protein engineering

More Trending

article thumbnail

Thermo Fisher continues viral vector withdrawal; lays off 300 employees

Pharmaceutical Technology

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

100
100
article thumbnail

GH Research leaps on psychedelic data in depression

pharmaphorum

After setbacks with psychedelics, phase 2b data with GH Research's GH001 for treatment-resistant depression could lift confidence in the category

94
article thumbnail

Moderna reports record for UK clinical trials in 2023/24

European Pharmaceutical Review

Two years after signing its strategic partnership with the UK government, Moderna, Inc. has made substantial R&D investment and progress in the UK, the company has declared. The Moderna Innovation and Technology Centre (MITC) began construction in April 2023 as the companys state-of-the-art R&D and manufacturing facility. [Moderna] was the biggest industry sponsor of clinical trials in the UK in 2023/24″ The site is anticipated to be fully operational later in 2025, ready to delive

article thumbnail

Novartis secures MHRA authorisation for ribociclib

PharmaTimes

Breast cancer therapy offers hope for patients at risk of recurrence

article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Sanofi increases ownership stake partaking in pharma buyback trend

Pharmaceutical Technology

Sanofi has agreed to purchase its own shares worth 2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.

Pharma 98
article thumbnail

Novo rises on Wegovy sales leap, but warns of a slowdown

pharmaphorum

Novo Nordisk is expecting greater competition and pricing pressure in the obesity and diabetes sectors this year.

article thumbnail

Industry Outlook 2025: The Rising Prominence of AI in Pharma

PharmaTech

In this interview, Pharmaceutical Technology discusses the trend of AI in pharma and how it may play out in 2025 and beyond with Ben Sidders from Biorelate.

Pharma 65
article thumbnail

Grifols collaborates with startup FcR Therapeutics to develop autoimmune therapies

PharmaTimes

Partnership aims to create recombinant nanobodies to treat immune disorders

71
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Denali’s Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval

MedCity News

Currently available therapies for Hunter syndrome dont cross the blood-brain barrier to address cognitive symptoms of the inherited enzyme deficiency. Denali Therapeutics’ technology gets its drug across the protective membrane, and the biotech plans to seek accelerated FDA approval in this rare disease. The post Denalis Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval appeared first on MedCity News.

FDA 101
article thumbnail

Super Bowl ad for copycat weight loss drugs stokes pharma power debate

Pharmaceutical Technology

Controversy surrounded Him & Hers commercial, called Sick of the System, in the lead up to Americas biggest sporting event.

Pharma 71
article thumbnail

BMS extends its cost-cutting drive by another $2bn

pharmaphorum

BMS is extending its bid to cut costs by $1.5bn before the end of this year, backed by 2,200 job cuts, adding a target of another $2bn by end-2027.

92
article thumbnail

Steps to Process Development Optimization

PharmaTech

The optimization of processes for the development and manufacture of biopharmaceuticals is pivotal for producing quality products.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Hemgenix shows efficacy among haemophilia B patients

PharmaTimes

CSL Behring's study reveals significant long-term benefits

article thumbnail

Fay Raises $50M to Expand Access to Nutrition Counseling Services

MedCity News

Fay’s $50 million Series B round was led by Goldman Sachs. In total, the company has raised $75 million. The post Fay Raises $50M to Expand Access to Nutrition Counseling Services appeared first on MedCity News.

95
article thumbnail

Fourth person receives eGenesis’ gene-edited pig kidney transplant

Pharmaceutical Technology

Tim Andrews underwent the procedure with the pig kidney as part of a three-person compassionate use study.

71
article thumbnail

Share in cystic fibrosis firm Sionna rise sharply after IPO

pharmaphorum

Sionna has closed its IPO, raising $191m for cystic fibrosis candidates that it thinks could be more effective than rivals from Vertex.

89
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Study Finds COVID-19 Infection Associated With More Severe Disease Compared With Flu, RSV

Pharmacy Times

Investigators noted that the differences between the 3 respiratory infections were not as pronounced during the 2023-2024 season.

61
article thumbnail

FDA grants Orphan Drug Designation to Ariceum cancer therapy

PharmaTimes

Designation follows promising preclinical data and FDA clearance

FDA 63
article thumbnail

A Guide to Boosting Healthcare Practice Performance

MedCity News

[Sponsored] A Data-Driven Guide to Patient Access Success highlights how focusing on data accuracy and relevance can enhance healthcare practice performance. The post A Guide to Boosting Healthcare Practice Performance appeared first on MedCity News.

article thumbnail

Eton secures US patent for diabetes insipidus treatment

Pharmaceutical Technology

Eton has secured a patent from the USPTO for its ET-600 product candidates desmopressin oral solution formulation for diabetes insipidus.

66
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Algiax non-opioid drug works in chronic neuropathic pain

pharmaphorum

A GABA-targeting drug developed by German Biotech Algiax has shown proof of concept in a chronic neuropathic trial trial.

83
article thumbnail

Video: GLP-1 Medications Revolutionize Obesity and Diabetes Care, With Exciting Advances on Horizon

Pharmacy Times

Donna Ryan discusses the landscape of GLP-1 medications and the lineup of indications that the drug class has received indications for in recent years.

Medical 61
article thumbnail

Qureight and Avalyn launch strategic partnership in pulmonary fibrosis

PharmaTimes

Partnership aims to leverage cutting-edge technology in clinical trials

63
article thumbnail

Patient-Facing AI: Separating Signal from Noise

MedCity News

LLMs, with their remarkable conversational abilities, are uniquely positioned to help solve this crisis. But as with the dotcom boom before it, the surge of AI ‘therapists’ has created a turbulent landscape where separating legitimate innovation from dangerous shortcuts isn’t straightforward. The post Patient-Facing AI: Separating Signal from Noise appeared first on MedCity News.

article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.